SEC Form 4 · accession 0001611650-16-000006
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Pearce
Officer — CHIEF OPERATING OFFICER · Director
Period of report
Jul 18, 2016
Accepted (ET)
Jul 22, 2016 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 18, 2016 | J | 1,000,000 | $0.00 | A | 2,876,125 | D |
Table II — derivative securities
No Table II lines on this filing.